Table 1 Sociodemographic characteristics and comorbidities between cohorts with and without hepatatis B virus (HBV) infection in Taiwan, 1998–2010 (n = 88980)
HBV cohort | Non-HBV cohort | ||
|---|---|---|---|
Variables | (n = 17796) N (%) | (n = 71184) N (%) | P |
Sex | 1.00 | ||
Men | 10428 (58.6) | 41712 (58.6) | |
Women | 7368 (41.4) | 29472 (41.4) | |
Age (year) | 1.00 | ||
18–39 | 8514 (47.8) | 34056 (47.8) | |
40–49 | 4914 (27.6) | 19656 (27.6) | |
50–59 | 2857 (16.1) | 11428 (16.1) | |
60–69 | 1146 (6.4) | 4584 (6.4) | |
≧ 70 | 365 (2.1) | 1460 (2.1) | |
Major comorbidities | |||
Diabetes | 1660 (9.3) | 5181 (7.3) | <0.001 |
Hypertension | 2511 (14.1) | 9020 (12.7) | <0.001 |
Coronary heart disease | 1039 (5.8) | 4392 (6.2) | 0.10 |
Hyperlipidemia | 2484 (14.0) | 66.71 (9.4) | <0.001 |
Cirrhosis | 638 (3.6) | 466 (0.7) | <0.001 |
Use of herbs containing aristolochic acid | 365 (2.1) | 931 (1.3) | <0.001 |
Geographic region | |||
Northern | 8967 (50.4) | 35017 (49.2) | |
Central | 4191 (23.6) | 16280 (22.9) | |
Eastern | 434 (2.4) | 1588 (2.2) | |
Southern | 4204 (23.6) | 18299 (25.7) | |
Urbanization level | 0.001 | ||
Urban | 5939 (33.4) | 22745 (32.0) | |
Suburban | 8216 (46.2) | 33438 (47.0) | |
Rural | 3640 (20.4) | 15002 (21.0) | |
Enrollee category | |||
1 | 9420 (52.9) | 35633 (50.0) | |
2 | 546 (3.1) | 1830 (2.6) | |
3 | 5297 (29.8) | 22157 (31.1) | |
4 | 2533 (14.2) | 11564 (16.3) | |
No. of medical visits (mean ± SD) | 17.7 ± 15.1 | 15.8 ± 15.3 | <0.001 |
Propensity score (mean ± SD) | 0.23 ± 0.09 | 0.19 ± 0.07 | <0.001 |
Charlson Comorbiditv Index score (mean ± SD) | 1.1 ± 1.2 | 0.6 ± 1.2 | <0.001 |